We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $5.49B
1-Year Est. Return 46.89%
This Fund
S&P 500
This Quarter Est. Return
+30.41%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$5.49B
AUM Growth
+$1.51B
Cap. Flow
+$309M
Cap. Flow %
5.62%
Top 10 Hldgs %
60.68%
Holding
58
New
14
Increased
15
Reduced
15
Closed
13

Top Buys

Rank Stock Value
1
A icon
Agilent Technologies
A
+$240M
2
TMO icon
Thermo Fisher Scientific
TMO
+$181M
3
DHR icon
Danaher
DHR
+$180M
4
GPN icon
Global Payments
GPN
+$175M
5
META icon
Meta Platforms (Facebook)
META
+$143M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$301M
2
AMD icon
Advanced Micro Devices
AMD
+$144M
3
DXC icon
DXC Technology
DXC
+$112M
4
GTM
ZoomInfo Technologies
GTM
+$95.1M
5
CNC icon
Centene
CNC
+$71M

Sector Composition

Rank Sector Weight
1 Healthcare 49.86%
2 Industrials 12.99%
3 Technology 12.58%
4 Consumer Discretionary 9.03%
5 Miscellaneous 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LAD icon
51
Lithia Motors
LAD
$8.14B
– –
-127,605
Closed -$31.9M
MYGN icon
52
Myriad Genetics
MYGN
$302M
– –
-5,411,978
Closed -$24.4M
QQQ icon
53
CALL
Invesco QQQ Trust
QQQ
$489B
– –
-328,200
Closed -$189M
SGRY icon
54
Surgery Partners
SGRY
$1.79B
– –
-1,800,000
Closed -$21.5M
USFD icon
55
US Foods
USFD
$23.2B
– –
-384,007
Closed -$35.4M
Z icon
56
Zillow
Z
$8.02B
– –
-789,670
Closed -$32.7M
GTM
57
ZoomInfo Technologies
GTM
$1.22B
– –
-15,905,242
Closed -$95.1M
LION icon
58
Lionsgate Studios
LION
$3.39B
– –
-2,778,781
Closed -$26.6M
1 2
3

Similar funds

GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Glenview Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Glenview Capital Management held 58 positions worth $5.49B, up 38% from $3.98B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Glenview Capital Management deployed $309M of net new capital in Q2 2026, opening 14 new positions and adding to 15 existing holdings. Its largest new stake was Agilent Technologies: 1,969,541 shares worth $262M.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 45% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was CVS Health, an estimated $301M trimmed.

  • Glenview Capital Management's largest Q2 2026 buy was Agilent Technologies: 1,969,541 shares worth $262M.
  • Glenview Capital Management added most to Thermo Fisher Scientific in Q2 2026, an estimated $181M increase.
  • Glenview Capital Management's biggest Q2 2026 reduction was CVS Health, cutting an estimated $301M.
  • Glenview Capital Management fully exited DXC Technology in Q2 2026, selling an estimated $112M.
  • Glenview Capital Management's ten largest holdings make up 61% of its $5.49B portfolio in Q2 2026.
  • Glenview Capital Management opened 14 new positions and closed 13 in Q2 2026.
  • Glenview Capital Management's portfolio value rose 38% quarter-over-quarter to $5.49B.

Based on Glenview Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.